Senate Hearing: The Critical Importance of Biomedical Research Funding

The Value of Biomedical Research

• 💡 Biomedical research is highlighted as a crucial investment that yields significant dividends for American families, leading to life-saving and life-enhancing discoveries.
• 🚀 The United States has historically been a global leader in scientific research and innovation, a position built on the hard work of researchers and a robust system of grant-based funding.
• 📈 This system has led to breakthroughs such as over 600 new cancer treatments approved by the FDA in the last 20 years and advancements in Alzheimer's and dementia research.

Threats to US Leadership

• ⚠️ Concerns are raised about potential funding cuts, policy uncertainties, and the arbitrary imposition of indirect cost caps that threaten to undermine America's leadership in biomedical innovation.
• 📉 China's significant investment in biomedical research has led to them catching up with the US in patents and publications, posing a competitive risk.
• 🚫 The abrupt cancellation of grants, proposed funding slashes, and layoffs of federal scientists are seen as actions that put national leadership at real risk.

Economic and Societal Impact

• 💰 Biomedical innovation has immense economic value, supporting jobs and driving global health standards.
• 🏥 Delays or halts in clinical trials and research due to funding issues could postpone or prevent the discovery of treatments and cures for diseases like Alzheimer's, type 1 diabetes, and various cancers.
• 🌍 The US biomedical research ecosystem is a complex network including industry, philanthropy, academia, government agencies, and patient advocates, all starting with federal funding.

Witness Testimonies and Concerns

• 🔬 Dr. Sudep Puriq emphasized that federal funding is the "light in the heat" for the ecosystem and warned that proposed cuts could mean the US would "have lost" the race in biomedical research.
• 🧫 Dr. Herman Holler stressed that federal funding for biomedical research is a national investment that drives innovation, fuels the economy, and protects health, urging support for high-risk, high-reward research and workforce training.
• 🩺 Dr. Carter Esam highlighted the FDA's vital role in safeguarding health and fostering innovation, noting that an under-resourced FDA could negatively impact investment in next-generation medical interventions.
• 🎗️ Dr. Barry Sleckman shared how federal investments have led to remarkable progress in cancer treatment, such as immunotherapy for metastatic melanoma, and stressed the importance of continued support for research and clinical trials.
• 👧 Emily Stenson shared her personal story of her daughter Charlie's battle with pediatric cancer, underscoring how access to clinical trials, made possible by research funding, is a lifeline for families and the devastating impact of funding cuts.

Policy and Funding Challenges

• 📊 The hearing addressed concerns about the proposed 15% cap on indirect costs, potential empoundment of FY2025 funds, and proposed catastrophic cuts in FY2026.
• 📉 Cuts to training grants and early career scientist funding were highlighted as detrimental to the next generation of researchers and America's future leadership in innovation.
• 🤝 There is a strong call for bipartisan cooperation to protect and strengthen the scientific enterprise, ensuring continued progress in treating and curing diseases.